Literature DB >> 1673145

Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes.

W W Cruikshank1, J L Greenstein, A C Theodore, D M Center.   

Abstract

At present, a naturally occurring soluble ligand for CD4 has not been well described. There is much evidence to indicate that MHC class II molecules can bind to CD4; however, binding of intact class II molecules under physiologic conditions has been difficult to demonstrate. We investigated whether a previously reported human lymphokine, lymphocyte chemoattractant factor (LCF), which was described for its effects on human CD4+ lymphocytes and monocytes, could associate directly with CD4 and induce the generation of second messengers. In the present study, we demonstrate that CD4 affinity-purified natural and recombinant LCF induced a rise in intracellular calcium and increased inositol trisphosphate generation in normal human CD4+ lymphocytes and murine T cell hybridomas infected to express human CD4. Cell lines lacking human CD4 or expressing human CD4 molecules that lack the intracytoplasmic domain did not demonstrate a change in either calcium or inositol trisphosphate. The effect of LCF was blocked by coincubation with either anti-CD4 antibody or Fab fragments from anti-CD4 antibody. These studies demonstrate direct interaction of a lymphokine with CD4 and generation of second messengers as a result of the interaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

2.  Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.

Authors:  Jian C Qi; Jing Wang; Sravan Mandadi; Kumiko Tanaka; Basil D Roufogalis; Michele C Madigan; Kenneth Lai; Feng Yan; Beng H Chong; Richard L Stevens; Steven A Krilis
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

3.  Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells.

Authors:  E Hermann; E Darcissac; T Idziorek; A Capron; G M Bahr
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

4.  Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q.

Authors:  H B Yeon; N M Lindor; J G Seidman; C E Seidman
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

5.  Interleukin 16 (IL-16). IUIS/WHO Standing Committee on Interleukin Designation.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

6.  Evidence for a role for the adaptive immune response in human term parturition.

Authors:  Nardhy Gomez-Lopez; Rodrigo Vega-Sanchez; Marisol Castillo-Castrejon; Roberto Romero; Karen Cubeiro-Arreola; Felipe Vadillo-Ortega
Journal:  Am J Reprod Immunol       Date:  2013-01-24       Impact factor: 3.886

7.  Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.

Authors:  W W Cruikshank; D M Center; N Nisar; M Wu; B Natke; A C Theodore; H Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection.

Authors:  Anjie Zhen; Stephan R Krutzik; Bernard R Levin; Saro Kasparian; Jerome A Zack; Scott G Kitchen
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

9.  Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16.

Authors:  David J Blake; Jonathon D Martiszus; Tia H Lone; Steven D Fenster
Journal:  Cytokine       Date:  2018-06-05       Impact factor: 3.861

10.  The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.

Authors:  A Pelchen-Matthews; I Boulet; D R Littman; R Fagard; M Marsh
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.